Peter Richard Steenland Iii, MD | |
7 Vanderbilt Park Dr, Carolina Spine And Neurosurgery Center, Asheville, NC 28803-1700 | |
(828) 255-7776 | |
(828) 274-7855 |
Full Name | Peter Richard Steenland Iii |
---|---|
Gender | Male |
Speciality | Neurosurgery |
Experience | 18 Years |
Location | 7 Vanderbilt Park Dr, Asheville, North Carolina |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1881814770 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207T00000X | Neurological Surgery | 2013-00901 (North Carolina) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Memorial Mission Hospital And Asheville Surgery Ce | Asheville, NC | Hospital |
Margaret R Pardee Memorial Hospital | Hendersonville, NC | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Mission Health Community Multispecialty Providers Llc | 9537468574 | 577 |
News Archive
New study reveals that FOXO proteins help maintain healthy cells in the cartilage of the joints.
A study in JAMA challenges the view that intravenous thrombolysis is a particularly risky procedure in stroke patients with subtherapeutic international normalized ratios.
Ocera Therapeutics, Inc. presented results yesterday from a Phase 2 proof-of-concept study of AST-120 (spherical carbon adsorbent) in the treatment of patients with non-constipating Irritable Bowel Syndrome (IBS) at DDW, the annual meeting of the American Gastroenterological Association. Data showed that subjects treated with AST-120 responded in a consistent manner with reduction in pain better than placebo at week four and at week eight, the primary time point for analysis. The company plans to initiate a Phase 2b study evaluating AST-120 in non-constipating IBS.
Evidence in a study led by researchers at the University of British Columbia along with University of Alabama at Birmingham School of Public Health Associate Professor Peter S. Hendricks, Ph.D., suggests hallucinogens such as psilocybin or LSD may have therapeutic potential for reducing intimate partner violence, or IPV.
The super committee might not have a staff director, rules in place, or a room to meet in, but leaders of the powerful budget-slashing panel insisted Wednesday that progress is being made. Co-chairs Sen. Patty Murray and Rep. Jeb Hensarling said in a joint-statement that they're engaged in "serious discussions" on the details.
› Verified 4 days ago
Entity Name | The Mcdowell Hospital Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1699772657 PECOS PAC ID: 2264343979 Enrollment ID: O20031107000487 |
News Archive
New study reveals that FOXO proteins help maintain healthy cells in the cartilage of the joints.
A study in JAMA challenges the view that intravenous thrombolysis is a particularly risky procedure in stroke patients with subtherapeutic international normalized ratios.
Ocera Therapeutics, Inc. presented results yesterday from a Phase 2 proof-of-concept study of AST-120 (spherical carbon adsorbent) in the treatment of patients with non-constipating Irritable Bowel Syndrome (IBS) at DDW, the annual meeting of the American Gastroenterological Association. Data showed that subjects treated with AST-120 responded in a consistent manner with reduction in pain better than placebo at week four and at week eight, the primary time point for analysis. The company plans to initiate a Phase 2b study evaluating AST-120 in non-constipating IBS.
Evidence in a study led by researchers at the University of British Columbia along with University of Alabama at Birmingham School of Public Health Associate Professor Peter S. Hendricks, Ph.D., suggests hallucinogens such as psilocybin or LSD may have therapeutic potential for reducing intimate partner violence, or IPV.
The super committee might not have a staff director, rules in place, or a room to meet in, but leaders of the powerful budget-slashing panel insisted Wednesday that progress is being made. Co-chairs Sen. Patty Murray and Rep. Jeb Hensarling said in a joint-statement that they're engaged in "serious discussions" on the details.
› Verified 4 days ago
Entity Name | Mission Hospitals Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1548532021 PECOS PAC ID: 0648189969 Enrollment ID: O20120316000506 |
News Archive
New study reveals that FOXO proteins help maintain healthy cells in the cartilage of the joints.
A study in JAMA challenges the view that intravenous thrombolysis is a particularly risky procedure in stroke patients with subtherapeutic international normalized ratios.
Ocera Therapeutics, Inc. presented results yesterday from a Phase 2 proof-of-concept study of AST-120 (spherical carbon adsorbent) in the treatment of patients with non-constipating Irritable Bowel Syndrome (IBS) at DDW, the annual meeting of the American Gastroenterological Association. Data showed that subjects treated with AST-120 responded in a consistent manner with reduction in pain better than placebo at week four and at week eight, the primary time point for analysis. The company plans to initiate a Phase 2b study evaluating AST-120 in non-constipating IBS.
Evidence in a study led by researchers at the University of British Columbia along with University of Alabama at Birmingham School of Public Health Associate Professor Peter S. Hendricks, Ph.D., suggests hallucinogens such as psilocybin or LSD may have therapeutic potential for reducing intimate partner violence, or IPV.
The super committee might not have a staff director, rules in place, or a room to meet in, but leaders of the powerful budget-slashing panel insisted Wednesday that progress is being made. Co-chairs Sen. Patty Murray and Rep. Jeb Hensarling said in a joint-statement that they're engaged in "serious discussions" on the details.
› Verified 4 days ago
Entity Name | Mission Health Community Multispecialty Providers Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1457719130 PECOS PAC ID: 9537468574 Enrollment ID: O20160426001883 |
News Archive
New study reveals that FOXO proteins help maintain healthy cells in the cartilage of the joints.
A study in JAMA challenges the view that intravenous thrombolysis is a particularly risky procedure in stroke patients with subtherapeutic international normalized ratios.
Ocera Therapeutics, Inc. presented results yesterday from a Phase 2 proof-of-concept study of AST-120 (spherical carbon adsorbent) in the treatment of patients with non-constipating Irritable Bowel Syndrome (IBS) at DDW, the annual meeting of the American Gastroenterological Association. Data showed that subjects treated with AST-120 responded in a consistent manner with reduction in pain better than placebo at week four and at week eight, the primary time point for analysis. The company plans to initiate a Phase 2b study evaluating AST-120 in non-constipating IBS.
Evidence in a study led by researchers at the University of British Columbia along with University of Alabama at Birmingham School of Public Health Associate Professor Peter S. Hendricks, Ph.D., suggests hallucinogens such as psilocybin or LSD may have therapeutic potential for reducing intimate partner violence, or IPV.
The super committee might not have a staff director, rules in place, or a room to meet in, but leaders of the powerful budget-slashing panel insisted Wednesday that progress is being made. Co-chairs Sen. Patty Murray and Rep. Jeb Hensarling said in a joint-statement that they're engaged in "serious discussions" on the details.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Peter Richard Steenland Iii, MD Po Box 602811, Charlotte, NC 28260-2811 Ph: (828) 213-1500 | Peter Richard Steenland Iii, MD 7 Vanderbilt Park Dr, Carolina Spine And Neurosurgery Center, Asheville, NC 28803-1700 Ph: (828) 255-7776 |
News Archive
New study reveals that FOXO proteins help maintain healthy cells in the cartilage of the joints.
A study in JAMA challenges the view that intravenous thrombolysis is a particularly risky procedure in stroke patients with subtherapeutic international normalized ratios.
Ocera Therapeutics, Inc. presented results yesterday from a Phase 2 proof-of-concept study of AST-120 (spherical carbon adsorbent) in the treatment of patients with non-constipating Irritable Bowel Syndrome (IBS) at DDW, the annual meeting of the American Gastroenterological Association. Data showed that subjects treated with AST-120 responded in a consistent manner with reduction in pain better than placebo at week four and at week eight, the primary time point for analysis. The company plans to initiate a Phase 2b study evaluating AST-120 in non-constipating IBS.
Evidence in a study led by researchers at the University of British Columbia along with University of Alabama at Birmingham School of Public Health Associate Professor Peter S. Hendricks, Ph.D., suggests hallucinogens such as psilocybin or LSD may have therapeutic potential for reducing intimate partner violence, or IPV.
The super committee might not have a staff director, rules in place, or a room to meet in, but leaders of the powerful budget-slashing panel insisted Wednesday that progress is being made. Co-chairs Sen. Patty Murray and Rep. Jeb Hensarling said in a joint-statement that they're engaged in "serious discussions" on the details.
› Verified 4 days ago
Dr. Eric L Rhoton, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 7 Vanderbilt Park Dr, Asheville, NC 28803 Phone: 828-255-7776 Fax: 828-247-7855 | |
Dr. Jon M Silver, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 7 Vanderbilt Park Dr, Asheville, NC 28803 Phone: 828-255-7776 Fax: 828-274-7855 | |
Dr. Richard A Lytle, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 7 Vanderbilt Park Dr, Asheville, NC 28803 Phone: 828-255-7776 Fax: 828-274-7855 | |
Dr. Steven M Stranges, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 7 Vanderbilt Park Dr, Asheville, NC 28803 Phone: 828-255-7776 Fax: 828-274-7855 | |
Dr. Wesley C Fowler Iii, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 7 Vanderbilt Park Dr, Asheville, NC 28803 Phone: 828-255-7776 Fax: 828-274-7855 | |
Dr. Ralph C Loomis, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 7 Vanderbilt Park Dr, Asheville, NC 28803 Phone: 828-255-7776 Fax: 828-274-7855 | |
Dr. Lary A Schulhof, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 7 Vanderbilt Park Dr, Asheville, NC 28803 Phone: 828-255-7776 Fax: 828-274-7855 |